WallStreetZenWallStreetZen

NASDAQ: AZN
ASTRAZENECA PLC Stock Ownership - Who owns ASTRAZENECA?

Buy AZN

Insider buying vs selling

Have ASTRAZENECA PLC insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

AZN Shareholders

What type of owners hold ASTRAZENECA PLC stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Price T Rowe Associates Inc6.08%94,229,869$6.07BInstitution
Wellington Management Group LLP3.01%46,691,035$3.01BInstitution
Primecap Management Co2.99%46,317,880$2.99BInstitution
Capital International Investors2.39%36,993,664$2.38BInstitution
Fisher Asset Management LLC1.35%20,842,845$1.34BInstitution
Gqg Partners LLC1.18%18,280,681$1.18BInstitution
Fmr LLC1.11%17,210,950$1.11BInstitution
Franklin Resources Inc0.99%15,377,355$991.07MInstitution
Bank Of America Corp0.72%11,169,891$719.90MInstitution
Cibc Private Wealth Group LLC0.60%9,240,598$595.56MInstitution

1 of 3

AZN vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AZN32.57%0.00%
NVS9.41%0.00%
MRK71.77%0.18%Net SellingNet Buying
BMY75.34%0.33%Net SellingNet Selling
ABBV66.98%0.14%Net SellingNet Selling

ASTRAZENECA Stock Ownership FAQ

Who owns ASTRAZENECA?

ASTRAZENECA (NASDAQ: AZN) is owned by 32.57% institutional shareholders, 0.00% ASTRAZENECA insiders, and 67.43% retail investors. Price T Rowe Associates Inc is the largest individual ASTRAZENECA shareholder, owning 94.23M shares representing 6.08% of the company. Price T Rowe Associates Inc's ASTRAZENECA shares are currently valued at $6.30B.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.